
The editor in chief of Evidence-Based Oncology, who was recently named medical director of Precision Medicine for The US Oncology Network, discussed milestones met and those still to be achieved.
There are plenty of unknowns concerning the financial aspects of ICD-10. Transitioning to the new codes could be a disaster for some providers. However, those who take into careful consideration their current clinical documentation and coding shortfalls and adjust them for ICD-10 specificity could see an entirely different outcome.
Providers can achieve positive financial outcomes from their ICD-10 transition by "preparing, perfecting and protecting" during rollout, said David Van Doren of IOD, Inc., a company that offers healthcare information management solutions to providers.
Read the full story:
Source: Healthcare Finance News





